Statistics
Publications
44
Citations
4.2K
H-Index
28
Active since
1992
Michael Shi is an author at Novartis (United States) specializing in medicine, pharmacology, and oncology.
Publications per year
1992–2025
44
44
Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer
Fabrice André, Thomas Bachelot, Mario Campone et al. · Clinical Cancer Research · 2013 · 313 citations
Medicine, Oncology, Pharmacology +14
Michael Shi, Amir Kugelman, Takeo Iwamoto et al. · Journal of Biological Chemistry · 1994 · 309 citations · Full text
Robert J. Motzer, Camillo Porta, Nicholas J. Vogelzang et al. · The Lancet Oncology · 2014 · 263 citations · Full text
Medicine, Oncology, Pharmacology +12
1–5 of 44